120 related articles for article (PubMed ID: 19203317)
1. Early detection of malignant pleural mesothelioma through measurement of soluble mesothelin-related protein and positron emission tomography.
O'Lone EL; Park EK; Sandrini A; Fogarty GB; Yates DH
Med J Aust; 2009 Feb; 190(3):158-9. PubMed ID: 19203317
[TBL] [Abstract][Full Text] [Related]
2. Recurrent hydropneumothorax as a presenting feature of malignant mesothelioma.
Guha K; Jones D; Hull JH; Ho TB
Eur J Intern Med; 2008 Jan; 19(1):63-4. PubMed ID: 18206605
[TBL] [Abstract][Full Text] [Related]
3. Simultaneous bilateral spontaneous hydropneumothorax: a rare presentation of bilateral malignant pleural mesothelioma.
Fayed HE; Woodcock VK; Grayez J
BMJ Case Rep; 2013 May; 2013():. PubMed ID: 23682089
[TBL] [Abstract][Full Text] [Related]
4. Soluble mesothelin-related protein in an asbestos-exposed population: the dust diseases board cohort study.
Park EK; Sandrini A; Yates DH; Creaney J; Robinson BW; Thomas PS; Johnson AR
Am J Respir Crit Care Med; 2008 Oct; 178(8):832-7. PubMed ID: 18583574
[TBL] [Abstract][Full Text] [Related]
5. Detection of malignant mesothelioma in asbestos-exposed individuals: the potential role of soluble mesothelin-related protein.
Creaney J; Robinson BW
Hematol Oncol Clin North Am; 2005 Dec; 19(6):1025-40, v. PubMed ID: 16325121
[TBL] [Abstract][Full Text] [Related]
6. Validity of mesothelin in occupational medicine practice.
Smolková P; Nakládalová M; Zapletalová J; Jakubec P; Vildová H; Kolek V; Petřek M; Nakládal Z
Int J Occup Med Environ Health; 2016; 29(3):395-404. PubMed ID: 26988879
[TBL] [Abstract][Full Text] [Related]
7. Significance of serum mesothelin in an asbestos-exposed population in the Czech Republic.
Jakubec P; Pelclova D; Smolkova P; Kolek V; Nakladalova M
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2015 Sep; 159(3):472-9. PubMed ID: 24781044
[TBL] [Abstract][Full Text] [Related]
8. Current status of screening for malignant pleural mesothelioma.
Pass HI; Carbone M
Semin Thorac Cardiovasc Surg; 2009; 21(2):97-104. PubMed ID: 19822280
[TBL] [Abstract][Full Text] [Related]
9. [Two cases of recurrent hydropneumothorax caused by malignant pleural mesothelioma].
Tanaka H; Iuchi K; Nanjou S; Ikeda M; Takana Y; Mori T
Nihon Kyobu Geka Gakkai Zasshi; 1996 Oct; 44(10):1877-81. PubMed ID: 8940843
[TBL] [Abstract][Full Text] [Related]
10. Serum mesothelin for early detection of asbestos-induced cancer malignant mesothelioma.
Creaney J; Olsen NJ; Brims F; Dick IM; Musk AW; de Klerk NH; Skates SJ; Robinson BW
Cancer Epidemiol Biomarkers Prev; 2010 Sep; 19(9):2238-46. PubMed ID: 20651076
[TBL] [Abstract][Full Text] [Related]
11. Mesothelin-related predictive and prognostic factors in malignant mesothelioma: a nested case-control study.
Roe OD; Creaney J; Lundgren S; Larsson E; Sandeck H; Boffetta P; Nilsen TI; Robinson B; Kjaerheim K
Lung Cancer; 2008 Aug; 61(2):235-43. PubMed ID: 18281122
[TBL] [Abstract][Full Text] [Related]
12. Serum and pleural fluid biomarkers for mesothelioma.
Creaney J; Robinson BW
Curr Opin Pulm Med; 2009 Jul; 15(4):366-70. PubMed ID: 19417672
[TBL] [Abstract][Full Text] [Related]
13. Combined CA125 and mesothelin levels for the diagnosis of malignant mesothelioma.
Creaney J; van Bruggen I; Hof M; Segal A; Musk AW; de Klerk N; Horick N; Skates SJ; Robinson BW
Chest; 2007 Oct; 132(4):1239-46. PubMed ID: 17646232
[TBL] [Abstract][Full Text] [Related]
14. Utility of osteopontin and serum mesothelin in malignant pleural mesothelioma diagnosis and prognosis assessment.
Grigoriu BD; Scherpereel A; Devos P; Chahine B; Letourneux M; Lebailly P; Grégoire M; Porte H; Copin MC; Lassalle P
Clin Cancer Res; 2007 May; 13(10):2928-35. PubMed ID: 17504993
[TBL] [Abstract][Full Text] [Related]
15. Soluble mesothelin in effusions: a useful tool for the diagnosis of malignant mesothelioma.
Creaney J; Yeoman D; Naumoff LK; Hof M; Segal A; Musk AW; De Klerk N; Horick N; Skates SJ; Robinson BW
Thorax; 2007 Jul; 62(7):569-76. PubMed ID: 17356060
[TBL] [Abstract][Full Text] [Related]
16. Molecular tumor markers for asbestos-related mesothelioma: serum diagnostic markers.
Maeda M; Hino O
Pathol Int; 2006 Nov; 56(11):649-54. PubMed ID: 17040286
[TBL] [Abstract][Full Text] [Related]
17. Establishment of a novel specific ELISA system for rat N- and C-ERC/mesothelin. Rat ERC/mesothelin in the body fluids of mice bearing mesothelioma.
Hagiwara Y; Hamada Y; Kuwahara M; Maeda M; Segawa T; Ishikawa K; Hino O
Cancer Sci; 2008 Apr; 99(4):666-70. PubMed ID: 18294289
[TBL] [Abstract][Full Text] [Related]
18. Lepidic intrapulmonary growth of malignant mesothelioma presenting as recurrent hydropneumothorax.
Wu H; Tino G; Gannon FH; Kaiser LR; Pietra GG
Hum Pathol; 1996 Sep; 27(9):989-92. PubMed ID: 8816899
[TBL] [Abstract][Full Text] [Related]
19. Serum mesothelin has a higher diagnostic utility than hyaluronic acid in malignant mesothelioma.
Grigoriu B; Chahine B; Zerimech F; Grégoire M; Balduyck M; Copin MC; Devos P; Lassalle P; Scherpereel A
Clin Biochem; 2009 Jul; 42(10-11):1046-50. PubMed ID: 19302997
[TBL] [Abstract][Full Text] [Related]
20. Blood tests for asbestos-related mesothelioma.
Maeda M; Hino O
Oncology; 2006; 71(1-2):26-31. PubMed ID: 17344668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]